Clinical trial testing fecal microbiota transplant for recurrent diarrheal disease begins
(PHYSorg.com Medicine & Health)

A research consortium recently began enrolling patients in a clinical trial examining whether fecal microbiota transplantation (FMT) by enema-putting stool from a healthy donor in the colon of a recipient-is safe and can prevent recurrent Clostridium difficile-associated disease (CDAD), a potentially life-threatening diarrheal illness. Investigators aim to enroll 162 volunteer participants 18 years or older who have had two or more episodes of CDAD within the previous six months.